PDCD1 and neoplasm: Moreover, by comparing the tumour size of anti-PD-1 mAb + Prop + Vehicle and anti-PD-1 mAb + Vehicle groups, anti-PD-1 mAb and Prop combined therapy showed better therapeutic effects than anti-PD-1 mAb alone (Fig. 1d, e).